X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (167) 167
male (125) 125
female (122) 122
middle aged (115) 115
gastroenterology & hepatology (112) 112
index medicus (109) 109
adult (104) 104
aged (58) 58
ulcerative-colitis (39) 39
young adult (37) 37
ulcerative colitis (36) 36
adolescent (35) 35
inflammatory bowel disease (35) 35
gastroenterology and hepatology (33) 33
risk factors (32) 32
crohn's disease (30) 30
crohns-disease (26) 26
therapy (26) 26
treatment outcome (26) 26
3121 internal medicine (23) 23
finland (22) 22
prospective studies (22) 22
diagnosis (21) 21
follow-up studies (21) 21
drug therapy, combination (20) 20
prognosis (20) 20
prevalence (19) 19
severity of illness index (19) 19
inflammatory-bowel-disease (18) 18
epidemiology (17) 17
inflammatory bowel diseases (17) 17
retrospective studies (17) 17
biopsy (16) 16
child (16) 16
finland - epidemiology (16) 16
gastroenterology (16) 16
genotype (16) 16
infliximab (16) 16
population (16) 16
ribavirin (16) 16
surgery (16) 16
genetics (15) 15
hepacivirus - genetics (15) 15
management (15) 15
case-control studies (14) 14
hepatitis c (14) 14
liver (14) 14
risk-factors (14) 14
time factors (14) 14
disease (13) 13
endoscopy, gastrointestinal (13) 13
hepatitis (13) 13
inflammation (13) 13
liver transplantation (13) 13
patients (13) 13
aged, 80 and over (12) 12
cholangitis (12) 12
cirrhosis (12) 12
feces - chemistry (12) 12
fibrosis (12) 12
genetic aspects (12) 12
infectious medicine (12) 12
infektionsmedicin (12) 12
interferon (12) 12
medicine (12) 12
microbiology (12) 12
primary biliary-cirrhosis (12) 12
sensitivity and specificity (12) 12
abridged index medicus (11) 11
antiviral agents - therapeutic use (11) 11
association (11) 11
cancer (11) 11
cholangiopancreatography, endoscopic retrograde (11) 11
drug therapy (11) 11
hepatitis c virus (11) 11
hepatitis c, chronic - drug therapy (11) 11
infectious diseases (11) 11
liver diseases (11) 11
natural-history (11) 11
recurrence (11) 11
registries (11) 11
remission induction (11) 11
antiviral agents - administration & dosage (10) 10
complications (10) 10
inflammatory bowel diseases - drug therapy (10) 10
liver - pathology (10) 10
medical research (10) 10
metaanalysis (10) 10
oncology (10) 10
primary sclerosing cholangitis (10) 10
ribavirin - administration & dosage (10) 10
surveys and questionnaires (10) 10
adenocarcinoma (9) 9
child, preschool (9) 9
cholangitis, sclerosing - pathology (9) 9
clinical medicine (9) 9
colitis, ulcerative - drug therapy (9) 9
crohn disease - genetics (9) 9
endoscopy (9) 9
fecal calprotectin (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9857, pp. 1909 - 1915
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2017, Volume 12, Issue 8, p. e0182924
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2016, Volume 11, Issue 5, p. e0155142
In this pilot study (RibaC), 58 hepatitis C virus (HCV) genotype 1 infected treatment-naive patients were randomized to (i) 2 weeks ribavirin double dosing... 
SUSTAINED VIROLOGICAL RESPONSE | GENETIC-VARIATION | RESISTANCE-ASSOCIATED VARIANTS | INTERFERON-FREE THERAPY | PLUS SOFOSBUVIR | MULTIDISCIPLINARY SCIENCES | IP-10 PREDICTS | HCV | COMBINATION | TREATMENT-NAIVE PATIENTS | SPONTANEOUS CLEARANCE | Hepacivirus - drug effects | Chemokine CXCL10 - blood | Ribavirin - blood | Humans | Middle Aged | Ribavirin - therapeutic use | Hemoglobins - metabolism | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Genotype | Male | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Dose-Response Relationship, Drug | Anemia - complications | Ribavirin - administration & dosage | Ribavirin - pharmacokinetics | Adult | Female | RNA, Viral - metabolism | Alanine Transaminase - metabolism | Kinetics | Chemokine CXCL10 - metabolism | Dose-response relationship (Biochemistry) | Hepatitis C | Drug therapy | Observations | Patient outcomes | Ribavirin | Therapy | Phosphorylation | Viruses | Infections | Hepatitis | Genotype & phenotype | Randomization | Hepatology | Gastroenterology | Hemoglobin | IP-10 protein | Drug dosages | Genotypes | Dosing | Antiviral agents | Anemia | Pharmacology | RNA polymerase | Ribonucleic acid--RNA | Medicine | Studies | Infectious diseases | Hospitals | Interferon | Hepatitis C virus | Pharmacokinetics | Infectious Medicine | Infektionsmedicin | RNA | Ribonucleic acid
Journal Article
Journal Article
Hepatology, ISSN 0270-9139, 08/2010, Volume 52, Issue 2, pp. 430 - 435
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2012, Volume 7, Issue 1, p. e29370
Background and Aims: Recently, several genome-wide association studies have revealed that single nucleotide polymorphisms (SNPs) in proximity to IL28B predict... 
GENETIC-VARIATION | IL28B | PLUS RIBAVIRIN | VIRUS-INFECTION | PEGINTERFERON ALPHA-2A | INTERLEUKIN 28B | BIOLOGY | TREATMENT RESPONSE | INSULIN-RECEPTOR SUBSTRATE-1 | UP-REGULATION | VIRAL KINETICS | Fatty Liver - genetics | Liver - virology | Inflammation - pathology | Genetic Predisposition to Disease | Liver - pathology | Fatty Liver - virology | Humans | Middle Aged | Fatty Liver - complications | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Alanine Transaminase - blood | Hepatitis C, Chronic - complications | Viral Load - genetics | Hepatitis C, Chronic - blood | Inflammation - complications | Interleukins - genetics | RNA, Viral - genetics | Aspartate Aminotransferases - blood | Polymorphism, Single Nucleotide - genetics | Adult | Female | Hepatitis C, Chronic - genetics | Medical research | Care and treatment | Liver | Genomics | Infection | Medicine, Experimental | Genetic aspects | Interferon | Single nucleotide polymorphisms | Hepatitis C virus | Chromosomes | Health aspects | Histochemistry | Oxidative stress | Phosphorylation | Variability | Genes | Chronic infection | Infections | Genomes | Single-nucleotide polymorphism | Ribavirin | Proteins | Hepatitis | Histopathology | Sterols | Hepatology | Gastroenterology | Pretreatment | Genotypes | Evaluation | Cytokines | Mortality | Histology | Patients | Insulin | Steatosis | Virology | Medicine | Infectious diseases | Genotyping | Biopsy | Hepatitis C | Clinical trials | Inflammation | Platelets | steatosis | Aspartate Aminotransferases | pathology | Alanine Transaminase | RNA | Viral | Mikrobiologi inom det medicinska området | Single Nucleotide | Viral Load | genetics | Interleukins | complications | Infektionsmedicin | blood | Fatty Liver | Chronic | Microbiology in the medical area | virology | Infectious Medicine | Hepacivirus | Polymorphism
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2014, Volume 134, Issue 1, pp. 189 - 196
Journal Article
by Weismüller, Tobias J and Trivedi, Palak J and Bergquist, Annika and Imam, Mohamad and Lenzen, Henrike and Ponsioen, Cyriel Y and Holm, Kristian and Gotthardt, Daniel and Färkkilä, Martti A and Marschall, Hanns-Ulrich and Thorburn, Douglas and Weersma, Rinse K and Fevery, Johan and Mueller, Tobias and Chaouillères, Olivier and Schulze, Kornelius and Lazaridis, Konstantinos N and Almer, Sven and Pereira, Stephen P and Levy, Cynthia and Mason, Andrew and Naess, Sigrid and Bowlus, Christopher L and Floreani, Annarosa and Halilbasic, Emina and Yimam, Kidist K and Milkiewicz, Piotr and Beuers, Ulrich and Huynh, Dep K and Pares, Albert and Manser, Christine N and Dalekos, George N and Eksteen, Bertus and Invernizzi, Pietro and Berg, Christoph P and Kirchner, Gabi I and Sarrazin, Christoph and Zimmer, Vincent and Fabris, Luca and Braun, Felix and Marzioni, Marco and Juran, Brian D and Said, Karouk and Rupp, Christian and Jokelainen, Kalle and Benito de Valle, Maria and Saffioti, Francesca and Cheung, Angela and Trauner, Michael and Schramm, Christoph and Chapman, Roger W and Karlsen, Tom H and Schrumpf, Erik and Strassburg, Christian P and Manns, Michael P and Lindor, Keith D and Hirschfield, Gideon M and Hansen, Bettina E and Boberg, Kirsten M and Int PSC Study Grp and International PSC Study Group and Region Östergötland and Avdelningen för inflammationsmedicin and Linköpings universitet and Institutionen för klinisk och experimentell medicin and Magtarmmedicinska kliniken and Hjärt- och Medicincentrum and Hälsouniversitetet
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 8, pp. 1975 - 1984.e8
Background & Aims Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary disorder associated with inflammatory bowel disease (IBD). We aimed to... 
Gastroenterology and Hepatology | Risk Stratification | Immune-Mediated Liver Disease | Autoimmune Liver Disease | Cholestasis | DOSE URSODEOXYCHOLIC ACID | RISK-FACTORS | LIVER-TRANSPLANTATION | ALKALINE-PHOSPHATASE | ULCERATIVE-COLITIS | NATURAL-HISTORY | CLINICAL PRESENTATION | PRIMARY BILIARY-CIRRHOSIS | PROGNOSTIC VARIABLES | GASTROENTEROLOGY & HEPATOLOGY | GENOME-WIDE ASSOCIATION | Crohn Disease - epidemiology | Multivariate Analysis | Liver Transplantation | Age Distribution | Prognosis | Humans | Middle Aged | Crohn Disease - surgery | Crohn Disease - mortality | Male | Colitis, Ulcerative - epidemiology | Incidence | Young Adult | Time Factors | Crohn Disease - diagnosis | Adult | Colitis, Ulcerative - surgery | Female | Retrospective Studies | Cholangitis, Sclerosing - surgery | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Europe - epidemiology | Chi-Square Distribution | Australia - epidemiology | Disease Progression | Phenotype | Cholangitis, Sclerosing - epidemiology | Colitis, Ulcerative - diagnosis | Colitis, Ulcerative - mortality | Sex Distribution | Cholangitis, Sclerosing - diagnosis | North America - epidemiology | Cholangitis, Sclerosing - mortality | Gastrointestinal diseases | Genetic aspects | Analysis | Colitis ulcerosa | Inflammation | Inflamació | Ulcerative colitis | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Gastroenterologi | Risk Stratification; Immune-Mediated Liver Disease; Autoimmune Liver Disease; Cholestasis | Klinisk medicin
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 6/2011, Volume 203, Issue 12, pp. 1748 - 1752
Journal Article